on CARMAT (EPA:ALCAR)
Update on CARMAT's judicial recovery
CARMAT, a specialist in artificial hearts, has announced an update on its receivership proceedings. These proceedings were initiated on July 1, 2025. A takeover bid submitted by HOUGOU was rejected by the Versailles Court due to the failure to lift the conditions precedent. Consequently, a petition for conversion into compulsory liquidation has been filed.
The court postponed its decision until November 25, 2025, leaving until November 3, 2025, for the submission of new proposals. CARMAT warns that without new offers, compulsory liquidation is likely, with heavy losses for shareholders and creditors.
In this context, the company remains focused on supporting the wearers of its artificial heart, Aeson®. Trading in CARMAT shares remains suspended until further notice.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all CARMAT news